Moderna
PulseAugur coverage of Moderna — every cluster mentioning Moderna across labs, papers, and developer communities, ranked by signal.
4 day(s) with sentiment data
-
FDA Approves Moderna mRNA Vaccine; Logarithms Explored
The FDA has unanimously approved Moderna's mRNA vaccine, a decision that signifies a major advancement in mRNA technology and is anticipated to significantly influence the healthcare sector. Separately, the concept of l…
-
New Limit therapy boosts liver repair in mice, human trials next year
New Limit has developed a single-dose cellular reprogramming therapy that significantly improves survival rates in mice with alcohol-induced liver damage. This therapy restores the liver's youthful resilience and regene…
-
AI tools streamline small business admin; Anthropic eyes IPO
Small businesses can now leverage AI for administrative tasks such as accounting, design, and market research, according to MIT Technology Review. The article highlights how AI models can handle basic work like organizi…
-
Moderna gets $50M for Ebola vaccine; Pixel Watch 5 possibly leaked
Moderna has received $50 million to develop an mRNA vaccine targeting the Bundibugyo strain of Ebola. This initiative aims to accelerate vaccine development amidst a current Ebola outbreak. Separately, the Pixel Watch 5…
-
New TMLE method improves vaccine effectiveness analysis with missing data
Researchers have developed a new targeted maximum likelihood estimation (TMLE) approach for analyzing test-negative design (TND) studies, particularly those with missing data in exposure variables. This semiparametric l…
-
FDA Commissioner Marty Makary Resigns Amidst Controversy and Upheaval
FDA Commissioner Dr. Marty Makary has resigned after a turbulent 13-month tenure marked by organizational upheaval and controversies. His initiatives to streamline drug approvals and increase transparency faced criticis…
-
Moderna partners with OpenAI to accelerate drug discovery with ChatGPT Enterprise
Moderna has partnered with OpenAI to integrate ChatGPT Enterprise across its operations, aiming to accelerate the development of mRNA medicines. The pharmaceutical company has focused on a comprehensive workforce transf…